Will Dixon is awarded Professorship of Digital Epidemiology by The University of Manchester
Congratulations to Will Dixon, BRU project lead, who has been appointed Professor of Digital Epidemiology at The University of Manchester.
Read moreNews & Events category:
NIHR Manchester Biomedical Research Centre
New Manchester study evaluates steps towards cost-effectiveness of implementing a personalised treatment approach for rheumatoid arthritis (RA) patients
New research findings published in Rheumatology aim to assess the initial steps of implementing a personalised treatment approach for rheumatoid arthritis (RA) patients in the NHS.
Read more
NIHR Manchester Musculoskeletal Biomedical Research Unit: A year in review 2015/16
The BRU has had another successful year continuing to address its overarching theme of treating arthritis; right first time.
Read more
Research News e-bulletin – August edition
The August edition of the Research News e-bulletin is now out
Read more
The NIHR Infrastructure Doctoral Training Camp: the Inside Scoop
Stephanie Shoop-Worrall blogs about her experience of the NIHR Infrastructure Doctoral Training Camp, which saw her work with six other trainees to put together a winning research grant proposal.
Read more
Creative project invites young people with arthritis to develop products and technology to help improve their life
An exciting new project called #DesignforMSK has been launched by the BRU, inviting young people to work with product designers, and research to design new products.
Read more
Centre for Musculoskeletal Research designated as a European rheumatology centre of excellence
The Centre for Musculoskeletal Research at the University of Manchester has recently been designated as a Centre of Excellence for the third time by European League Against Rheumatism (EULAR).
Read more
New research suggests high levels of drug antibodies and patients not taking medication as instructed are associated with low drug levels leading to poor treatment response
New research suggests that high levels of drug antibodies and inadequate patient adherence are associated with poor response to biologic drug treatment in rheumatoid arthritis (RA) patients.
Read more
